Study: HAART reduces CMV in children born to HIV-positive mothers

06/25/2009 | Medscape (free registration)

Highly active anti-retroviral therapy used to prevent mother-to-child transmission of HIV-1 also helps prevent congenital cytomegalovirus infection, according to a study of almost 4,800 children born to HIV-infected mothers between 1993 and 2004. Despite the reduction, however, the French researchers said congenital CMV infection remains prevalent among children born to HIV-1-infected mothers, so systemic screening is needed.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY